JT
Tamburini Bonnefoy, Jérôme
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia | Blood advances |  | 2025 | 7 | 4 | ||
| Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma : Insights from real-life clinical practice | Cancer reports | | 2024 | 19 | 30 | ||
| Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation | Leukemia | | 2024 | 3 | 0 | ||
| Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models | Science translational medicine |  | 2024 | 88 | 0 | ||
| Selective haematological cancer eradication with preserved haematopoiesis | Nature | | 2024 | 64 | 21 | ||
| AMPK activation induces immunogenic cell death in AML | Blood advances | | 2023 | 33 | 6 | ||
| Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia | Blood advances | | 2023 | 79 | 21 | ||
| Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia | Leukemia | | 2023 | 45 | 7 | ||
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | 2023 | 260 | 52 | ||
| An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML | Cancer discovery | | 2022 | 305 | 237 | ||
| RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia | Leukemia | | 2022 | 33 | 15 | ||
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | 2022 | 140 | 43 | ||
| AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia | Cancers | | 2021 | 148 | 60 | ||
| Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia | Science advances | | 2015 | 156 | 106 | ||
| The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation | Blood | | 2010 | 162 | 290 |
